DRUG STRATEGIES DRUG STRATEGIES PROMOTES MORE EFFECTIVE APPROACHES TO THE NATION'S DRUG PROBLEMS.
DRUG STRATEGIES has received 10 grants from 4 known foundation funders. Revenue decreased from $1,867,462 in 2023 to $3,639 in 2024. Most recent reported revenue: $3,639.
Annual Revenue
$3,639
Known Funders
4
Grants Received
10
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $3,639 | $358,403 | $1,673,953 |
| 2023 | $1,867,462 | $375,191 | $1,905,837 |
| 2022 | $73,344 | $237,590 | $365,764 |
| 2021 | $182,093 | $284,100 | $462,658 |
| 2020 | $118,239 | $284,473 | $772,173 |
| 2019 | $192,630 | $312,252 | $733,871 |
| 2018 | $156,286 | $360,700 | $843,669 |
| 2017 | $256,711 | $318,984 | $1,053,745 |
Top Funders
NEW YORK, NY
NEW YORK, NY
NEW YORK, NY
NEW YORK, NY
NEW YORK, NY
NEW YORK, NY
NEW YORK, NY
New York, NY
PRINCETON, NJ
HAYWARD, CA
Key Personnel
From 2024 IRS 990 filing
MATHEA FALCO
EXECUTIVE DIR/PRESIDENT
DR A THOMAS MCLELLAN
DIRECTOR
MARNI VLIET
DIRECTOR
AMBASSADOR JAMES R JONES
BOARD CHAIR
MICHAEL KANTOR
DIRECTOR
MORRIS PANNER
DIRECTOR
LOUISE BRYSON
DIRECTOR
MARIAN WRIGHT EDELMAN
DIRECTOR
Frequently Asked Questions
Other Nonprofits in District of Columbia
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.